DOSSIER · 13F Holders · Q3 2026
NWBO

NW Biotherapeutics

8 institutions still hold NW Biotherapeutics as of Q3 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 66737P600·8 13F holders·last filed Sep 30, 2026
Market cap
—
13F value held
$390K
visible holders
Holders
8
filers reporting
Concentration
62.27%
COMPASS FINANCIAL MANAGEMENT LLC #1
top holder share
AI Holders Summary · Q3 2026

8 institutions reported NWBO in Q3 2026. COMPASS FINANCIAL MANAGEMENT LLC leads at 62.3% of the visible book.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
COMPASS FINANCIAL MANAGEMENT LLC
CIK 0002148724
$243K1.6M0.03%Q3 2026
02
Moloney Securities Asset Management, LLC
CIK 0001697934
$128K535K0.02%Q3 2025
03
Opus Capital Group, LLC
CIK 0001330325
$9K60K0.00%Q3 2026
04
Ethos Financial Group, LLC
CIK 0001954242
$6K39K0.00%Q3 2026
05
Williams Jones Wealth Management, LLC.
CIK 0001788587
$4K25K0.00%Q3 2026
06
Markowski Investments
CIK 0002149795
$1561K0.00%Q3 2026
07
McIlrath & Eck, LLC
CIK 0001701714
$1246000.00%Q1 2026
08
HANTZ FINANCIAL SERVICES, INC.
CIK 0001071061
$02500.00%Q3 2026
Insiders at NW Biotherapeutics
Boynton Alton L →Bosch Marnix L →Malik Navid →Jasinowski Jerry J →Powers Linda F →Goldman Leslie J. →Black Cofer →Cognate Bioservices, Inc. →